Literature DB >> 24515529

Comment on complications following antidotal use of intravenous lipid emulsion therapy (Levine et Al., J Med Toxicol 2013).

Ami M Grunbaum1, Sophie Gosselin, Brian M Gilfix, David W Blank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24515529      PMCID： PMC4057532          DOI： 10.1007/s13181-014-0388-1

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  4 in total

1.  Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation.

Authors:  Goce Dimeski; Brock W Jones
Journal:  Biochem Med (Zagreb)       Date:  2011       Impact factor: 2.313

2.  Glycerol blanking in triglyceride assays: is it necessary?

Authors:  T G Cole
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

3.  Other complications following lipid emulsion therapy : Re: Levine M, Skolnik AB, Ruha AM, et al. (2013) Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol Dec 13. [Epub ahead of print].

Authors:  Evan S Schwarz; Anna M Arroyo-Plasencia; Michael E Mullins
Journal:  J Med Toxicol       Date:  2014-06

4.  Analytical interferences resulting from intravenous lipid emulsion.

Authors:  Ami M Grunbaum; Brian M Gilfix; Sophie Gosselin; David W Blank
Journal:  Clin Toxicol (Phila)       Date:  2012-11       Impact factor: 4.467
  4 in total
  1 in total

1.  Prolonged Laboratory Interference After Administration of Intravenous Lipid Emulsion Therapy.

Authors:  Kelly Johnson-Arbor; Lauren Salinger; Stephen Luczycki
Journal:  J Med Toxicol       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.